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Summary 
We have introduced the human fetal y- and adult 
j3-globin genes into the germ line of mice. Analysis of 
the resulting transgenic mice shows that the human 
r-globin gene is expressed like an embryonic mouse 
globin gene; the human fi-globin gene is expressed (as 
previously shown) like an adult mouse globin gene. 
These results imply that the regulatory signals for 
tissue- and developmental stage-specific expression 
of the globin genes have been conserved between 
man and mouse but that the timing of the signals has 
changed. Because the two genes are expressed differ- 
ently, we introduced a hybrid @globIn gene con- 
struct. The combination of the regulatory sequences 
resulted in the expression of the hybrid gene at all 
stages in all the murine erythroid tissues. 
Introduction 
The murine p-like globin locus comprises seven genes 
closely linked within 65 kb of DNA (Jahn et al., 1960; Leder 
et al., 1960), organized as follows: 5’-y-phO-phl-ph2-ph3- 
p@-pmin-3’. In normal mouse development primitive nu- 
cleated erythrocytes formed in the yolk sac blood islands 
are released into circulation at about day 9.5 of gestation. 
These embryonic cells persist in circulation until about 
day 16.5 of gestation (Kovach et al., 1967) and contain the 
embryonic globin chains y and z (Fantoni et al., 1967). 
These chains are encoded by the genes y and phi, 
respectively (Hansen et al., 1962; Farace et al., 1964). The 
mouse fetal liver becomes the major site of erythrocyte 
formation shortly after day 10.5 of gestation and remains 
a site of erythropoiesis almost to birth (Rifkind et al., 
1969). The liver-generated non-nucleated erythrocytes 
are released for the first t ime into circulation on day 12.5 
of gestation and, in contrast to erythrocytes in man, con- 
tain only adult globin chains encoded by the adult prnaj 
and pmin genes (Konkel et al., 1979). At about day 16.5 of 
gestation, synthesis of the same adult globin chains be- 
gins in the spleen and bone marrow, which remain the 
sites of erythropoiesis in adult life (Borghese, 1959). 
The human b-like globin genes are a cluster of five ac- 
tive genes in the order 5’-~-~y+-6+3’ occupying ap- 
proximately 60 kb of DNA. During development the differ- 
ent genes are expressed in different tissues and at 
different times, i. e., the embryonic E gene is expressed 
in the yolk sac, the fetal oy and Av genes are expressed 
primarily in the fetal liver, and the adult S and p genes are 
expressed primarily in bone marrow (reviewed by Mania- 
tis et al., 1961). Humans, as opposed to most species, in- 
cluding mice (see above), have undergone a process of 
fetal recruitment resulting in a separate set of fetal genes. 
This has also been observed in other primates, in goats, 
and in sheep (Schon et al., 1981; Kretschmer et al., 1981). 
In the past few years considerable progress has been 
made in our understanding of the DNA sequences neces- 
sary for the transcription of the globin genes (Dierks et al., 
1983; Grosveld et al., 1982). More recently, by DNA- 
mediated gene transfer into cultured mouse erythroleuke- 
mia (MEL) cells, it has been shown that expression of the 
human P-globin gene, but not the E- and y-globin genes, 
is regulated during MEL cell differentiation (Wright et 
al., 1983; Chao et al., 1983; Spandidos and Paul, 1982). 
The results with hybrid genes suggest that the DNA se- 
quences that regulate fl-globin gene expression during 
MEL cell differentiation are located both 5’ and 3’ of the 
translation initiation site (Wright et al., 1984; Charnay et 
al., 1984). Although very useful, the cell systems simulate 
in vivo erythropoiesis only in part, and they therefore have 
certain disadvantages, in particular, for studying the 
switch from embryonic to fetal to adult globin gene ex- 
pression. 
A more powerful approach to the study of switching 
mechanisms has been the development of methods to in- 
troduce foreign genes successfully into the germ line of 
mice (Gordon et al., 1980). A number of genes that have 
been introduced into mice by microinjection of fertilized 
eggs have shown, when expressed, the same regulation 
characteristics as their endogenous counterparts (Brin- 
ster et al., 1981; Palmiter et al., 1962; Grosschedl et al., 
1984; Swift et al., 1984; Hanahan, 1985; Magram et al., 
1985; Adams et al., 1985). To study the molecular mecha- 
nisms involved in the developmental regulation of globin 
gene expression, we introduced the human adult P-globin 
and fetal y-globin genes into the germ line of mice. We 
show that in the transgenic mouse system the human 
P-globin gene is regulated as an adult globin gene (see 
also Magram et al., 1985; Townes et al., 1985), but the hu- 
man fetal +-globin gene is regulated as an embryonic glo- 
bin gene. To show whether the multiple regulatory se- 
quences that have been identified in cell culture systems 
are required for this complete developmental process, we 
have also introduced a recombinant globin gene con- 
struct containing the 5’ part of the human Ay gene linked 
to the 3’ part of the human P-globin gene. The results 
show that this recombinant gene is correctly transcribed 
both in the embryonic and the adult stage of mouse devel- 
opment. 
Results 
Expression of Human +Globin and 
P-Globin mRNA in Mouse Embryos 
A 3.3 kb Hindlll fragment containing the entire human +- 
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Figure 1. Expression of Human Au- and B-Globin Genes in Transgenic Mouse Tissues 
(A) Expression of the human +$globin gene in transgenic mouse tissues. Ninety-one eggs survived the microinjection and were transferred into 
the oviducts of pseudopregnant recipients; 19 mice were born. Seven transgenic pups were identified by Southern blot hybridization of DNA isolated 
from tail biopsies and were found to carry between two and 50 copies of the +-globin gene. Shown is the expression pattern of line ~18. 
Total RNA was extracted from the following tissues (see Experimental Procedures): day 10.5 embryonic yolk sac and blood, day 13.5 fetal liver 
and blood, and adult blood. Thirty micrograms of this RNA was hybridized at 52°C to a 3’ end-labeled probe derived from the 3’ end of the human 
%globin gene (see diagram). Seven micrograms of RNA from an %-globin-producing cell line (PUTKO; Klein et al., 1980; Rutherford et al., 1981) 
was used as a positive control. Normal transcription termination of the Au-globin gene produces an mRNA that protects 188 nucleotides of a 3’ end- 
labeled EcoRI-Hindlll fragment from Sl digestion. The shorter fragment in the positive lanes is a variable Sl nuclease analysis artifact (Wright et 
al., 1983). Autoradiography was for 18 hr at -70% with an intensifying screen. Sizes (at left) were estimated with an end-labeled Hinfl digest of 
pBR322. 
(l3) Expression of the human p-globin gene in transgenic mouse tissues. Ten mice were born after P-globin gene microinjection and transfer of eggs 
lo oviducts. Two of these carried the complete p-globin gene. The mouse carrying five copies of the gene was bred to homozygocity. Shown is the 
b-globin gene expression pattern of line b7. 
Total RNA was extracted from different tissues of mice carrying the human b-globin gene; 30 pg of this RNA was hybridized at 52OC to a S’end- 
labeled probe derived from the 3’end of the human @globin gene (see diagram). One nanogram of sickle-cell RNA was used as a positive control, 
which was visible only after long exposures. Normal transcription termination of the human @globin gene promoter produces an mRNA that protects 
a 212 nucleotide probe fragment from Sl digestion (Wright et al., 1983). The different lanes represent mRNA from adult mouse blood and brain, 
day 15.5 fetal blood and liver, and day 10.5 embryonic blood and yolk sac. Autoradiography was for 112 hr at -70% with an intensifying screen. 
Sizes were estimated with an end-labeled Hinfl digest of pBR322 DNA. 
370 nucleotides of 3’-flanking DNA was microinjected pref- 
erably into the male pronucleus of F2 (CBA x C57BIMO) 
zygotes (see legend, Figure 1). Of the seven transgenic 
lines obtained, one line was a high-copy chimeric line and 
another was very slow breeding. Therefore, these two 
lines were not included in this study. Two of the five re- 
maining lines were found to express the human Ay-globin 
gene in the same developmental stage, although at differ- 
ent levels (data not shown). 
Figure 1 shows the expression pattern of line ~18 by Sl 
nuclease protection assays on RNA samples isolated 
from different transgenic t issues throughout development 
(see Experimental Procedures). The RNA samples were 
initially assayed for the presence of human 9-globin 
mRNA by a probe derived from the 3’ end of the human 
y-globin gene (Figure IA). A 168 nucleotide fragment is 
protected from Sl nuclease digestion by the correctly ter- 
minated human fetal Ay-globin mRNA. As shown in Fig- 
ure lA, at 10.5 days of development both the embryonic 
yolk sac (lane 1) and blood (lane 2) RNA samples protect 
a 168 nucleotide fragment corresponding to the correct 
9-globin mRNA 3’ end, as well as some smaller frag- 
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Figure 2. Expression of a Human Hybrid 5’~+3’-Globin Gene in 
Transgenic Mouse Tissues 
One hundred seventy-two eggs survived the microinjection and were 
transferred into pseudopregnant recipients; 25 mice were born. Seven 
of these were found to be transgenic, and they carried between 1-l 00 
copies of the hybrid gene. One line was a very slow breeder and there- 
fore was excluded from this study. Out of the remaining six, three were 
found to express the human hybrid globin gene. Shown is the expres- 
sion pattern obtained with mouse ~811. 
Total RNA was extracted from the following tissues (see Experimen- 
tal Procedures): day 10.5 and 11.5 yolk sac and day 12.5 and 13.5 
liver. Ten micrograms of this RNA was hybridized at 52% to a 300 
nucleotide Bgll-Apal 5’ end-labeled probe derived from the 5’ end of 
the human %-globin gene. Normal transcription from the %-globin 
gene promoter produces an mRNA that protects a probe fragment of 
90 nucleotides from Sl digestion. Seven micrograms of PUTKO cell 
RNA (see Figure 1) was used as a positive control (Klein et al., 1980; 
Rutherford et al., 1981). Lanes 1,2 and 3,4 were joined from the same 
autoradiograph to facilitate presentation of the results. 
The two insets at the bottom show the autoradiographic signals ob- 
tained from Sl nuclease protection assays of probes specific for f3hl 
and 8”” mRNAs using 1 ug of total RNA. The 8hl probe was a 255 
nucleotide Hinfl fragment derived from the third exon of the 8hl gene, 
and the 8”” probe was a 700 nucleotide Hindlll-Ncol fragment de- 
rived from the second exon of the BrnaJ gene. Specific activities of 
these two probes and time of exposure of the autoradiograph were 
equalized to allow a comparison of the ratio of the endogenous em- 
bryonic to fetal globin signal. Sizes were estimated from an end- 
labeled Hinfl digest of pBR322 DNA. 
ments that represent a known Sl artifact (e. g., Wright et 
al., 1983). In contrast, expression of the 9 gene is shut 
off in day 13.5 liver (Figure lA, lane 3) as found for the em- 
bryonic mouse genes (see below). Just as is the case for 
the mouse embryonic mRNA, the human y-globin mRNA 
is still present in day 13.5 blood (Figure lA, lane 4), albeit 
in decreased amounts in comparison with day 10.5 blood. 
This leftover signal represents the decreasing amount of 
embryonic yolk sac-derived erythrocytes that continue to 
be present until day 16.5 of development (Kovach et al., 
1967). No *-globin mRNA can be detected in adult blood 
(Figure lA, lane 5) or nonerythropoietic t issues of any de- 
velopmental stage (data not shown). A 5’Sl analysis of the 
same RNA samples also showed correct initiation of tran- 
scription (not shown, but see below). 
These results show that the fetal human globin gene be- 
haves as an embryonic mouse gene in the mouse de- 
velopmental cycle, as might be predicted from previous 
studies (Czelusniak et al., 1962; Hill et al., 1984; Hardies 
et al., 1984). After fetal recruitment the human y genes 
may be subjected to a shift in the timing of the appear- 
ance of Vans-acting signal(s), or, alternatively, an altera- 
tion may occur in the &-acting sequences and/or fac- 
tor(s) in fetal erythroid cells. Our  results indicate that the 
mouse embryonic factor(s) still act on the human y gene 
sequences and correctly regulate expression of the hu- 
man 9 gene as an embryonic gene. Hence, we favor the 
first model. Our  results also demonstrate that the 3.3 
kb Hindlll Au-globin gene fragment introduced into the 
mouse system contains sufficient information to drive 
transcription in a tissue- and developmental stage-spe- 
cific manner. 
To determine the pattern of expression of a foreign hu- 
man P-globin gene and subsequently use it as a control 
for our hybrid globin gene experiments (see below), we 
also introduced a 5’ Hpal-3’ Clal human DNA fragment 
containing the adult human 6-globin gene with 0.6 kb of 
5’-flanking DNA and 2.5 kb of 3’-flanking DNA into the 
germ line of transgenic mice. Figure 1B shows an Sl 
nuclease protection assay on RNA sample8 isolated from 
erythroid and nonerythroid transgenic mouse tissues at 
different stages of development. At 10.5 days neither yolk 
sac RNA (Figure lB, lane 6) nor blood RNA (Figure lB, 
lane 5) shows a positive protection signal. At 15.5 days of 
development human 6-globin mRNA is abundant in fetal 
liver (Figure lB, lane 4) and fetal blood (Figure lB, lane 3). 
In the adult stage, human 6-globin mRNA continues to ac- 
cumulate in blood (Figure lB, lane l), but in brain tissue 
the signal is not detectable (Figure lB, lane 2). These ex- 
periments confirm earlier studies (Magram et al., 1985; 
Townes et al., 1985) showing that transgenic mice carry- 
ing the human adult 6-globin gene can express the gene 
correctly in a tissue-specific and developmentally regu- 
lated manner. 
Because different expression patterns for the human fe- 
tal and adult globin genes in transgenic mice are ob- 
served, this experimental system offers the possibility of 
defining the DNA sequences involved in developmental 
regulation by using human y-globin, 6globin hybrid gene 
constructs. 
Expression of a Hybrid Y-y-p-3 Gene 
Throughout Mouse Development 
To begin defining the DNA sequences involved in the 
regulated expression of either the human +$ or y-globin 
genes, we microinjected a hybrid gene construct into 
mouse fertilized eggs. The 5’ part of the human *-globin 
gene (up to the BamHl site of the second exon) was ad- 
joined to the complementary 3’part of the human 6-globin 
gene. This construct was chosen on the basis of K562 and 
MEL cell experiments showing that (at least) the 5’ half of 
the y-globin gene contains sequences responsible for its 
expression in embryonic/fetal cell types (Kioussis et al., 
1965; Ley and Bodine, personal communication) and that 
the 3’ end (in addition to the 5’end) of the human P-globin 
gene contains regulatory sequences involved in its ex- 
pression in adult cells (Wright et al., 1964; Charnay et al., 
1964). 
The 5’-HindIll+-BamHI-6-Clal-3’ hybrid gene, contain- 
ing the same 5’ sequences as in the 5-globin gene frag- 
ment and the same 3’-flanking sequences as in the 
P-globin gene fragment, was microinjected into mouse 
zygotes (see Experimental Procedures and Figure 2). 
Three mice expressed the human hybrid globin gene at 
the same developmental stages in a tissue-specific man- 
ner, although the total level of RNA varied between mice 
(data not shown). 
Figure 2 shows the expression pattern of line ~611 (car- 
rying approximately five copies of the foreign DNA) as 
determined by 5’-end Sl nuclease protection assays on 
RNA samples isolated from different transgenic tissues 
throughout development. Human globin mRNA levels were 
determined in samples from day 10.5 and 11.5 yolk sacs 
(Figure 2, lanes 1 and 2) and day 12.5 and 13.5 livers (Fig- 
ure 2, lanes 3 and 4). The 90 nucleotide protected frag- 
ment represents correct initiation of transcription from the 
hybrid gene (Figure 2, control lane). Globin-specific RNA 
synthesis is restricted to the two hemopoietic tissues of 
the developing mouse embryo, and RNA continues to ac- 
cumulate in adult blood (data not shown). To confirm that 
the ratio between embryonic yolk sac and fetal liver mRNA 
levels for the hybrid yp-globin gene is the same as the nor- 
mal ratio between the endogenous mouse genes, we per- 
formed a quantitative Sl nuclease analysis of the same 
RNA samples with probes of the same specific radioactiv- 
ity for endogenous phi and pm@ transcripts. The insets in 
Figure 2 show that a similar ratio of embryonic yolk sac 
globin mRNA to fetal liver globin mRNA is found, although 
it should be noted that the overall levels of expression for 
the foreign gene are lo-fold lower than for the endoge- 
nous globin genes in this particular mouse. The IOW- 
intensity protected band in the day 11.5 yolk sac RNA sam- 
ple probed with the 5’ 6”“’ probe (Figure 2, lane 2, bot- 
tom) may represent either early-circulating, non-nucle- 
ated erythrocytes of liver origin in the yolk sac sample or 
a very low level of transcription of the 8ma-globin gene in 
the yolk sac. The latter possibility would be similar to very 
recent evidence that shows a low level of transcription of 
the human y-globin gene in human yolk sac (Peschle et 
al., 1965). 
Discussion 
Our results clearly show that the manipulation of regula- 
tory elements has resulted in a new developmental ex- 
pression pattern for the hybrid gene: there is an em- 
bryonic stage due to the 5’ half of the y-giobin gene and 
a fetal/adult stage due to the 3’ half of the j3-globin gene. 
This implies that the r-globin gene that is first activated in 
the mouse is not (irreversibly) inactivated in the adult 
stage, since the factors acting on the 3’ 6-globin se- 
quences lead to an active expression of the “normally” si- 
lent y-globin promoter. This would be comparable to the 
human in vivo situation: normally the y-globin gene is not 
expressed in adult erythroid cells, but it can be stimulated 
to express reasonably efficiently by erythropoietic stress 
or by natural deletion mutations leading to hereditary per- 
sistence of fetal hemoglobin. in the latter case, it has been 
suggested that the y-giobin gene is brought in proximity 
to a (nonglobin) enhancing element, which is normally lo- 
cated a long distance from the 3’side of the locus (for re- 
view, see Collins and Weissman, 1964). 
The fact that the human @globin gene contains a 3’ele- 
ment, which can positively regulate a (y-giobin) promoter 
that is normally not expressed in adult erythroid cells, is 
in agreement with similar results obtained in MEL cells 
(Wright et al., 1964). it should be pointed out that the 
y-globin gene alone is transcribed in MEL cells and that 
the addition of the 3’ 6-globin gene only regulates its ex- 
pression, i. e., causes a stimulation of transcription over 
a basal level after differentiation rather than an activation 
from zero. In the case of the y-giobin gene, this dis- 
crepancy is probably due to a bypass of some activation 
control mechanism in the MEL cell experiments that 
results from the transfection/dominant marker selection 
method used to ensure integration of the newly introduced 
DNA into an actively expressing chromatin structure 
(Smithies et al., 1965). Experiments with the y-, and p-, 
and yp-giobin transgenes in mice are in complete agree- 
ment with transfection experiments in K562 ceils. In those 
cells an introduced y-giobin gene is correctly expressed 
even when only the 5’half of the gene is present, although 
an introduced j3-giobin gene is not expressed (Kioussis et 
al., 1965). The lack of 6-globin gene expression is solely 
caused by 5’-end sequences, as determined by hybrid 
gene transfections. in contrast 3’-end 6-globin sequences 
have no influence on an active or inactive promoter in 
K562 cells (Kioussis et al., 1985; Antoniou et al., unpub- 
lished data). Together these results suggest that in the 
simplest model the 5’ sequences might be involved in an 
on/off, positive/negative regulation of the gene (possibly 
by factors such as reported by Emerson et al. [1984]), 
whereas the S’sequences might act only on an already ac- 
tivated (but not necessarily expressing) gene. For exam- 
ple, the absence or presence of some Vans-acting fac- 
tor(s) might act on the 5’sequences to lead to the first (low 
level of) expression of the 6-globin gene in human fetal 
liver in vivo. Additional factors or a changed balance of 
factors in a later stage would interact with the 5’and 3’se- 
quences to give fully active expression. Of course, more 
complicated models are possible in which the multiple 
components only specifically interact with each other to 
yield regulated expression. 
It should be noted that only a fraction (30%-50%) of the 
transgenic mice express the foreign globin gene, and they 
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do so at extremely variable levels (Magram et al., 1985; 
Townes et al., 1985; and our results). This has also been 
seen in other systems, with the exception of the a-fetopro- 
tein gene when it is introduced with a large S’flanking se- 
were digested for two hr at 20% with 3000 U of Sl nuclease in 300 
pl of 200 mM NaCI, 30 mM NaOAc (pH 4.8) 2 mM Zn.S04. The DNA 
protected from Sl digestion was ethanol-precipitated and then elec- 
trophoresed on 8% urea-polyacrylamide gels. 
quence (Krumlauf and Tilghman, personal communica- Acknowledgments 
tion). This variable expression is attributed to a position 
effect, i. e., a dependence on the activity of the site of in- 
tegration of the foreign gene in the host genome. This ac- 
tually implies that yet another level of control is not 
properly exerted and that some regulatory sequences are 
absent from the newly introduced DNA. In the case of the 
globin genes, these could be some sort of multigene lo- 
cus-activating sequences, clearly different from and dom- 
inant over the tissue- and developmental stage-specific 
sequences, which are directly in cis to the globin genes 
as described above. The absence of such sequences 
would lead to position effects such as those observed in 
vivo for particular thalassemias (Kioussis et al., 1983) or 
in transgenic mice as described above. Possible candi- 
dates for such sequences might be the extreme DNAase 
l-hypersensitive sites far upstream of the s-globin gene 
and far downstream of the f3-globin gene, which could de- 
fine an erythroid-active domain (Tuan et al., 1985). 
Experimental Procedures 
Microinjection and Animal Treatments 
F2 hybrid fertilized eggs of CBA x C57Bl110 parents were isolated, and 
pronuclei were injected with approximately 2 pl of a solution containing 
approximately 2 pg/ml of DNA fragments in TE buffer (10 mM %-is, pH 
7.5; 1 mM EDTA). The eggs that survived the microinjection were in- 
cubated overnight in culture medium. The next morning, only the two- 
cell stage embryos were transferred into the oviducts of recipient pseu- 
dopregnant females (for review, see Brinster et al., 1985). After birth 
and weaning, the pups were analyzed for the presence of the injected 
DNA by Southern blot analysis of tail genomic DNA (Southern, 1975). 
To obtain embryonic tissues for expression analysis, appropriate 
matings were set up. The day the mating plug was observed was desig 
nated day 0.5, and embryos at the appropriate stage of development 
were dissected and washed in phosphate-buffered saline (PBS) con- 
taining 10 U/ml heparin to remove maternal blood contamination. 
Transgenic embryos in each litter were determined by placenta dot blot 
analysis (e. g., Brinster et al., 1985). Total RNA was prepared from the 
dissected tissues that proved to carry the foreign globin genes (see be- 
low). In some cases mice were made anemic by three injections (every 
12 hr) of a 0.4% phenylhydrazine solution (Cheng et al., 1974) at a dose 
of 0.2 ml per 25 g of bodyweight. 
Purification of RNA from Mouse Tissues 
Whole tissues were washed in PBS, and cells were lysed by homogeni- 
zation in 8 M  guanidinium chloride (Chirgwin et al., 1979). The homog- 
enate was phenol-extracted; nucleic acids were ethanol-precipitated, 
dissolved in 10 mM his (pH 7.5) 10 mM MgClz. 50 mM NaCI, and 
treated with RNAase-free DNAase. RNA was phenol-extracted and 
ethanol-precipitated. Concentrations were determined from the absor- 
bance at 280 nm and confirmed by electrophoresis on 2% agarose 
gels; the latter also showed that the RNA preparations were un- 
degraded. 
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